KR101076209B1 - 고혈당증 치료 또는 예방용 또는 혈당 안정용 효모 세포벽 - Google Patents

고혈당증 치료 또는 예방용 또는 혈당 안정용 효모 세포벽 Download PDF

Info

Publication number
KR101076209B1
KR101076209B1 KR1020067002769A KR20067002769A KR101076209B1 KR 101076209 B1 KR101076209 B1 KR 101076209B1 KR 1020067002769 A KR1020067002769 A KR 1020067002769A KR 20067002769 A KR20067002769 A KR 20067002769A KR 101076209 B1 KR101076209 B1 KR 101076209B1
Authority
KR
South Korea
Prior art keywords
yeast cell
cell wall
agent
hyperglycemia
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020067002769A
Other languages
English (en)
Korean (ko)
Other versions
KR20060037432A (ko
Inventor
루시엔 르사프르
Original Assignee
르사프르 에 꽁빠니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 르사프르 에 꽁빠니 filed Critical 르사프르 에 꽁빠니
Publication of KR20060037432A publication Critical patent/KR20060037432A/ko
Application granted granted Critical
Publication of KR101076209B1 publication Critical patent/KR101076209B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020067002769A 2003-08-11 2004-08-10 고혈당증 치료 또는 예방용 또는 혈당 안정용 효모 세포벽 Expired - Fee Related KR101076209B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP03018222.4 2003-08-11
EP03018222 2003-08-11
EP03020253.5 2003-09-08
EP03020253 2003-09-08

Publications (2)

Publication Number Publication Date
KR20060037432A KR20060037432A (ko) 2006-05-03
KR101076209B1 true KR101076209B1 (ko) 2011-10-24

Family

ID=34276722

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067002769A Expired - Fee Related KR101076209B1 (ko) 2003-08-11 2004-08-10 고혈당증 치료 또는 예방용 또는 혈당 안정용 효모 세포벽

Country Status (17)

Country Link
US (2) US7459159B2 (https=)
EP (1) EP1663266B1 (https=)
JP (2) JP4808619B2 (https=)
KR (1) KR101076209B1 (https=)
AU (1) AU2004267928B2 (https=)
BR (1) BRPI0413481A (https=)
CA (1) CA2534791C (https=)
DK (1) DK1663266T3 (https=)
EA (1) EA009677B1 (https=)
ES (1) ES2405934T3 (https=)
MA (1) MA28072A1 (https=)
MX (1) MXPA06001741A (https=)
NO (1) NO20061138L (https=)
NZ (1) NZ545594A (https=)
PL (1) PL1663266T3 (https=)
PT (1) PT1663266E (https=)
WO (1) WO2005021015A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006117566A (ja) * 2004-10-20 2006-05-11 Asahi Breweries Ltd 糖代謝改善剤
JP2007195444A (ja) * 2006-01-26 2007-08-09 Asahi Food & Healthcare Ltd ダイエット飲食品
EP2062588A4 (en) * 2006-08-24 2011-06-08 Kirin Holdings Kk COMPOSITION FOR TREATING A SKIN CONDITION
JP5238166B2 (ja) * 2007-02-02 2013-07-17 株式会社ヤクルト本社 インターロイキン１２産生抑制剤
FR2919187B1 (fr) 2007-07-25 2009-11-27 Lesaffre & Cie Utilisation d'ecorces de levure pour le traitement et/ou la prevention de l'hyperinsulinemie.
FR2949064B1 (fr) * 2009-08-14 2011-10-07 Lesaffre & Cie Nouvelles compositions destinees a la prevention et/ou au traitement du diabete
FR2978967B1 (fr) * 2011-08-09 2020-03-20 Lesaffre Et Compagnie Ecorces de levure enrichies en vitamine d2, compositions les contenant, leur procede de preparation, leurs utilisations et dispositif permettant la mise en oeuvre du procede
MD4216C1 (ro) * 2012-08-15 2013-11-30 Институт Микробиологии И Биотехнологии Академии Наук Молдовы Tulpină de drojdii Saccharomyces cerevisiae - producătoare de manani
WO2017179691A1 (ja) * 2016-04-14 2017-10-19 テーブルマーク株式会社 血糖値低下用又はｇｉ値低減用の食品組成物又は組み合わせ
US20190307823A1 (en) * 2016-05-17 2019-10-10 KOHJIN Life Sciences Co., Ltd. Yeast extract having diabetes prevention effect
IT201600069379A1 (it) * 2016-07-04 2018-01-04 Prosol S P A Composizione sostanzialmente costituita da pareti cellulari di lievito e procedimento per la sua preparazione
PL3685681T3 (pl) 2019-01-23 2024-10-21 Lesaffre Et Compagnie Produkt drożdżowy i zawierająca go kompozycja do zastosowania jako środek prebiotyczny

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19835767A1 (de) * 1998-08-07 2000-02-17 Kulicke Werner Michael Verfahren zur Gewinnung hochmolekularer biologisch aktiver immunmodulierender Polysaccharide aus Hefe Saccharomyces Cerevisiae
EP1094117A1 (fr) * 1999-10-22 2001-04-25 LESAFFRE et Cie Poudre de mannoprotéines soluble
FR2825004A1 (fr) * 2001-05-22 2002-11-29 Bio Springer Produit dietetique satiant

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5774072A (en) * 1980-10-29 1982-05-10 Yamanouchi Pharmaceut Co Ltd Granule of dietary fiber and its preparation
US4992540A (en) * 1984-11-28 1991-02-12 Massachusetts Institute Of Technology Glucan composition and process for preparation thereof
JPS61167622A (ja) * 1985-01-22 1986-07-29 Asahi Breweries Ltd 糖尿病コントロ−ル剤
US4962094A (en) * 1988-10-28 1990-10-09 Alpha Beta Technology, Inc. Glucan dietary additives
KR19980703564A (ko) * 1993-12-28 1998-11-05 빌르에르 고 가용성 섬유의 시리얼 식품
DE4413023A1 (de) * 1994-04-18 1995-10-19 Hoechst Ag Verfahren zur Gewinnung eines Faktors mit insulinartiger Wirkung aus Hefeextrakt
AUPN166195A0 (en) * 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
AUPN398295A0 (en) * 1995-07-05 1995-07-27 Carlton And United Breweries Limited Chemical compounds and processes for their production
US5773426A (en) * 1996-06-07 1998-06-30 Masaki Shirota Proteoglucan and antidiabetic drug thereof
CA2266929A1 (en) * 1996-09-25 1998-04-02 Graceline Limited Beta-glucan products and extraction processes from cereals
US20040023923A1 (en) * 2000-07-03 2004-02-05 Morgan Keith Raymond Cold water soluble beta-glucan product and process for preparing the same
CN100391439C (zh) * 2001-04-27 2008-06-04 味之素株式会社 免疫增强剂
EP1393738A4 (en) * 2001-06-01 2004-11-17 Ajinomoto Kk MEDICINE AGAINST DIABETES
US20030118989A1 (en) * 2001-12-21 2003-06-26 Carsten Rosenow Differential isolation of cellular content for biological assays

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19835767A1 (de) * 1998-08-07 2000-02-17 Kulicke Werner Michael Verfahren zur Gewinnung hochmolekularer biologisch aktiver immunmodulierender Polysaccharide aus Hefe Saccharomyces Cerevisiae
EP1094117A1 (fr) * 1999-10-22 2001-04-25 LESAFFRE et Cie Poudre de mannoprotéines soluble
FR2825004A1 (fr) * 2001-05-22 2002-11-29 Bio Springer Produit dietetique satiant

Also Published As

Publication number Publication date
AU2004267928A1 (en) 2005-03-10
MA28072A1 (fr) 2006-08-01
US20090022758A1 (en) 2009-01-22
BRPI0413481A (pt) 2006-10-17
NO20061138L (no) 2006-05-10
US20060257422A1 (en) 2006-11-16
EP1663266B1 (fr) 2013-02-20
CA2534791C (fr) 2014-10-28
ES2405934T3 (es) 2013-06-04
PL1663266T3 (pl) 2013-07-31
NZ545594A (en) 2009-09-25
DK1663266T3 (da) 2013-05-13
JP4808619B2 (ja) 2011-11-02
JP2007501829A (ja) 2007-02-01
WO2005021015A1 (fr) 2005-03-10
CA2534791A1 (fr) 2005-03-10
US7459159B2 (en) 2008-12-02
EA200600402A1 (ru) 2006-08-25
JP2011178794A (ja) 2011-09-15
KR20060037432A (ko) 2006-05-03
PT1663266E (pt) 2013-04-30
AU2004267928B2 (en) 2010-10-21
MXPA06001741A (es) 2006-05-12
EA009677B1 (ru) 2008-02-28
EP1663266A1 (fr) 2006-06-07

Similar Documents

Publication Publication Date Title
US20090022758A1 (en) Yeast cell walls for the treatment or prevention of hyperglycemia or for the stabilization of glycemia
JP5530354B2 (ja) 高インスリン血症の治療および／または予防のための酵母細胞壁の使用
DK2266582T3 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING DYSBIOSIS IN CONNECTION WITH ENTERAL ADMINISTRATION OF ANTIBIOTICS
JP4305785B1 (ja) プリン体吸収抑制剤及び血中尿酸値低減剤
TW200831114A (en) Activity enhancer for detoxifying enzyme
CN100377719C (zh) 用于治疗或预防高血糖症或用于稳定血糖的酵母细胞壁
US5773426A (en) Proteoglucan and antidiabetic drug thereof
AU2005242204B2 (en) Remedies for diabetes mellitus
DK2266581T3 (en) PHARMACEUTICAL COMPOSITION OF ANTIBIOTICS AND prebiotics FOR PREVENTION AND TREATMENT OF DYSBIOSE IN ANTIBACTERIAL THERAPY
JP2006117566A (ja) 糖代謝改善剤
WO2022195212A1 (fr) Inhibiteurs glycosidiques de levure
TWI487529B (zh) 用於降低胰島素抗性之組合物
CN110038004A (zh) Ae作为制备治疗改善糖尿病药品食品及相关制剂的应用
JP2006213607A (ja) 尿酸値低下剤

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20141019

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20141019

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000